Paris, France

Jean-Claude Ameisen

This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Claude Ameisen. Retrieved from https://idiyas.com/inventor/jean-claude-ameisen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jean-Claude Ameisen: Innovator in Cell Death Induction

Introduction

Jean-Claude Ameisen is a prominent inventor based in Paris, France. He is known for his significant contributions to the field of cell biology, particularly in the area of inducing cell death. His innovative work has implications for medical research and therapeutic applications.

Latest Patents

Ameisen holds a patent for the "Use of novel agents inducing cell death in synergy with interferons." This invention focuses on the use of novel agents that promote cell death, specifically an agent that facilitates the overexpression of the PML protein in nuclear bodies. When combined with interferons, this approach aims to induce the death of undesirable cells and stimulate an immune response.

Career Highlights

Throughout his career, Jean-Claude Ameisen has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and the National Institute of Health and Medical Research. His research has been pivotal in advancing our understanding of cellular processes and their applications in medicine.

Collaborations

Ameisen has collaborated with notable colleagues, including Frédérique Quignon and Hugues De The. Their joint efforts have contributed to the advancement of knowledge in the field of cell death and immune response.

Conclusion

Jean-Claude Ameisen's innovative work in the induction of cell death represents a significant advancement in medical research. His contributions continue to influence the field and hold promise for future therapeutic developments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…